EP3458080

POLYPEPTIDES MODULATING SIGLEC DEPENDENT IMMUNE RESPONSES

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    22.5.2017
  • EP published:
    10.7.2024
  • EP application number:
    17729037.6
  • Max expiry date:
    21.5.2037
  • Title in English:
    POLYPEPTIDES MODULATING SIGLEC DEPENDENT IMMUNE RESPONSES
  • Language of the patent:
    English

Timeline

Today
22.5.2017EP application
10.7.2024EP Publication

Owner

  • Name:
    Octapharma AG
  • Address:
    Seidenstrasse 2, 8853 Lachen, CH

Inventor

  • Name:
    KANNICHT, Christoph
  • Address:
    10967 Berlin, DE
  • Name:
    WINGE, Stefan
  • Address:
    12050 Årsta, SE
  • Name:
    KOHLA, Guido
  • Address:
    12205 Berlin, DE
  • Name:
    SOLECKA-WITULSKA, Barbara
  • Address:
    12167 Berlin, DE

Priority

  • Number:
    16170690
  • Date:
    20.5.2016
  • Country:
    EP

Classification

  • Categories:
    A61K 38/00, A61K 38/36, A61K 38/37, C07K 14/755

Upload documents